News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

8,150 stories indexed, page 61 of 136

🇺🇸Jan 14Industrysolidbio.com

Featured signal

Letter to the Duchenne Community

Publisher

Solid Biosciences

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Solid BiosciencesOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🌍Jan 13Industrycerbios.swiss

Investments Plan 2026

Cerbios-Pharma SAOriginal source

🇺🇸Jan 13Devicesir.idexx.com

IDEXX Announces CEO Succession

IDEXX LaboratoriesOriginal source

🌍Jan 13Industryoramed.com

Oramed and Lifeward Announce Strategic Transaction

Oramed PharmaceuticalsOriginal source

🇬🇧Jan 13Researchstemcells.cam.ac.uk

CSCI's Teichmann Lab and GSK announce new partnership to advance our understanding of the role of cells and tissues in disease, paving the way for new medical breakthroughs

Cambridge Stem Cell InstituteOriginal source

🇯🇵Jan 13pharma_equipmentprodcms.ulvac.co.jp

Presentation at the IEEE Hybrid Bonding Symposium (HBS 2026)

Ulvac (Pharma)Original source

🇯🇵Jan 13Devicessysmex.co.jp

Sysmex Selected for CDP 2025 âClimate Changeâ A List

Sysmex (Global)Original source

🌍Jan 13Industrycuris.com

Emavusertib in Combination With FOLFOX/PD-1 Inhibitor ± Trastuzumab as First-Line Treatment for Untreated Unresectable Gastric and Esophageal Cancer ASCO-GI 2026 Poster

CurisOriginal source

🌍Jan 13Mediainsitro.com

Introducing insitro’s TherML™: Rapidly engineering the right therapeutic for the right target

InsitroOriginal source

🌍Jan 13Mediainsitro.com

insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design

InsitroOriginal source

🇺🇸Jan 12Industryclinicalink.com

Clinical ink Announces SPUR™ Adherence Solution for Cardiometabolic Disease Management in the US

Clinical InkOriginal source

🇺🇸Jan 12Industrysolidbio.com

Letter to the FA Community

Solid BiosciencesOriginal source

🇺🇸Jan 12CDMOagcbio.com

Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production

AGC BiologicsOriginal source

🌍Jan 12Regulatoryacrohealth.org

ACRO Announces Doug Peddicord Retirement after 24 Years

ACRO AssociationOriginal source

🌍Jan 11Industrybenitec.com

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

Benitec BiopharmaOriginal source

🇺🇸Jan 10Industryvikingtherapeutics.com

Neil Aubuchon - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Jan 10Industryvikingtherapeutics.com

Karen Modesto, MD - Viking Therapeutics

Viking Therapeutics (IR)Original source

🌍Jan 10Researchcatalystcr.com

Tailored Approach Supports Bladder Cancer Breakthrough

Catalyst Clinical ResearchOriginal source

🇺🇸Jan 10Industryvikingtherapeutics.com

Marianne Mancini - Viking Therapeutics

Viking Therapeutics (IR)Original source

🇺🇸Jan 10Industryvikingtherapeutics.com

Greg Zante - Viking Therapeutics

Viking Therapeutics (IR)Original source

🌍Jan 9Researchuib.no

Biology may influence who benefits from ECT treatment

University of BergenOriginal source

🇫🇷Jan 9Industrypierre-fabre.com

Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology

Pierre FabreOriginal source

🇯🇵Jan 9Industrysanten.com

01.09.2026 Press Release IR News Launch of Aflibercept kit for IVT inj. 40 mg/mL Bayer

Santen PharmaceuticalOriginal source

🇺🇸Jan 9Industryordaos.bio

ordaos.bio

Ordaos BioOriginal source

🇫🇷Jan 9Industrycellectis.com

Cellectis Announces 2026 Strategy and Catalysts

CellectisOriginal source

🇺🇸Jan 9CROmedidata.com

From Activism to Advocacy: Building Empathetic Technology in Clinical Trials, Backed by Data

Medidata SolutionsOriginal source

🇺🇸Jan 9Industrylighthorsetx.com

Light Horse Therapeutics selected by BioSpace as one of the hottest new life sciences companies in the United States for 2026

Light Horse TherapeuticsOriginal source

🌍Jan 9Medialemsurgical.com

NVIDIA Releases New Physical AI Models as Global Partner LEM Surgical Unveils Next-Generation Robot

LEM Surgical (Dynamis Spine Robot)Original source

🇺🇸Jan 9Industrycapsida.com

An Important Update Regarding Our CAP-002 Program: A Letter to the STXBP1 Community

Capsida BiotherapeuticsOriginal source

🌍Jan 8Researchcatalystcr.com

Transforming Cancer Treatment with the Power of the Immune System

Catalyst Clinical ResearchOriginal source

🌍Jan 8Researchuib.no

Researchers have created the first map of lipid transport in cells

University of BergenOriginal source

🌍Jan 8Regulatorysahpra.org.za

Warning: Selenium and zinc picolinate-containing products for children

SAHPRA South AfricaOriginal source

🇺🇸Jan 8Devicespathai.com

PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight® Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows

PathAIOriginal source

🇩🇪Jan 8Researchcharite.de

Whooping cough vaccination during pregnancy strengthens the immune system in newborns

Charité - Universitätsmedizin Berlin (EN)Original source

🇺🇸Jan 8Devicesbtig.com

BTIG Announces Strategic Hire for TMT Investment Banking

BTIGOriginal source

🌍Jan 8Industrydayonebio.com

Lydia’s story

Mersana TherapeuticsOriginal source

🇺🇸Jan 8Researchpodcasters.spotify.com

The long game of American reindustrialization

Lux CapitalOriginal source

🇺🇸Jan 8Researcharchventure.com

D-Wave Quantum acquires ARCH-backed Quantum Circuits to accelerate the development of quantum computers

ARCH Venture PartnersOriginal source

🇺🇸Jan 7Industryir.codexis.com

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

CodexisOriginal source

🌍Jan 7Industryoramed.com

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

Oramed PharmaceuticalsOriginal source

🌍Jan 7Mediascience37.com

Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards

Science 37Original source

🌍Jan 7Researchhelsinki.fi

Arkadiankadun siltaremontti aiheuttaa muutoksia liikennejärjestelyihin Luonnontieteellisen museon lähistöllä

Helsinki University ResearchOriginal source

🇺🇸Jan 7Industryneogenomics.com

Precision testing options for pathologists

NeoGenomicsOriginal source

🇺🇸Jan 7Industryneogenomics.com

Partners in cancer care

NeoGenomicsOriginal source

🇺🇸Jan 7Industrybambusatx.com

Bambusa Therapeutics Announces First Patient Dosed in Phase Ib Proof-of-Concept COPD Study of BBT002, Reinforcing Bispecific Pipeline Momentum

Bambusa TherapeuticsOriginal source

🌍Jan 6Medialemsurgical.com

LEM Surgical Showcased in NVIDIA CES 2026 Keynote

LEM Surgical (Dynamis Spine Robot)Original source

🌍Jan 6Industrynimbustx.com

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment

Nimbus TherapeuticsOriginal source

🇫🇷Jan 6Industrypierre-fabre.com

Pierre Fabre, un modèle d'excellence en actionnariat salarié

Pierre FabreOriginal source

🌍Jan 6Industryabelzeta.com

AbelZeta to Attend 44th Annual J.P. Morgan Healthcare Conference and Join Panel Discussion

AbelZeta PharmaOriginal source

🌍Jan 6Regulatorycssp.gob.sv

Números de Contacto de Consejo Superior de Salud Pública

Consejo Superior de Salud Pública (El Salvador)Original source

🇺🇸Jan 6CROinvestor.medpace.com

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

MedpaceOriginal source

🇩🇰Jan 5Regulatorylaegemiddelstyrelsen.dk

Updating of summaries of product characteristics due to changed ATC codes for 2026

Danish Medicines AgencyOriginal source

🌍Jan 5Industryskyebioscience.com

Working with Halozyme ENHANZE® Technology for Higher Dosing

Skye BioscienceOriginal source

🌍Jan 5Industryskyebioscience.com

Using Arecor’s Arestat Technology to Increase Drug Dosing

Skye BioscienceOriginal source

🌍Jan 5Industryskyebioscience.com

Unlocking Solutions to Deliver Higher Doses

Skye BioscienceOriginal source

🇯🇵Jan 5Researchmed.kyoto-u.ac.jp

Prof. Akiyuki Taruno has taken up his post in the Cellular and Molecular Physiology

Kyoto University Faculty of MedicineOriginal source

🇯🇵Jan 5Devicesolympus-global.com

Olympus to Present at J.P. Morgan Healthcare Conference

Olympus MedicalOriginal source

🌍Jan 5Industryrss.globenewswire.com

GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026

GH ResearchOriginal source

🇨🇦Jan 5Industryir.bauschhealth.com

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Bausch Health (IR News)Original source

🇺🇸Jan 3Regulatoryciscrp.org

The Evolution of Health Literacy: Challenges, Opportunities for Trial Recruitment in the Digital Age

CISCRP Patient InfoOriginal source

Pharmaceutical industry news

Search-friendly hub pages

Regulatory Updates

Clinical Trial Watch

Drug Pipeline

Every signal, indexed and searchable

Latest indexed stories

Letter to the Duchenne Community

Investments Plan 2026

IDEXX Announces CEO Succession

Oramed and Lifeward Announce Strategic Transaction

CSCI's Teichmann Lab and GSK announce new partnership to advance our understanding of the role of cells and tissues in disease, paving the way for new medical breakthroughs

Presentation at the IEEE Hybrid Bonding Symposium (HBS 2026)

Sysmex Selected for CDP 2025 âClimate Changeâ A List

Emavusertib in Combination With FOLFOX/PD-1 Inhibitor ± Trastuzumab as First-Line Treatment for Untreated Unresectable Gastric and Esophageal Cancer ASCO-GI 2026 Poster

Introducing insitro’s TherML™: Rapidly engineering the right therapeutic for the right target

insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design

Clinical ink Announces SPUR™ Adherence Solution for Cardiometabolic Disease Management in the US

Letter to the FA Community

Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production

ACRO Announces Doug Peddicord Retirement after 24 Years

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

Neil Aubuchon - Viking Therapeutics

Karen Modesto, MD - Viking Therapeutics

Tailored Approach Supports Bladder Cancer Breakthrough

Marianne Mancini - Viking Therapeutics

Greg Zante - Viking Therapeutics

Biology may influence who benefits from ECT treatment

Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology

01.09.2026 Press Release IR News Launch of Aflibercept kit for IVT inj. 40 mg/mL Bayer

ordaos.bio

Cellectis Announces 2026 Strategy and Catalysts

From Activism to Advocacy: Building Empathetic Technology in Clinical Trials, Backed by Data

Light Horse Therapeutics selected by BioSpace as one of the hottest new life sciences companies in the United States for 2026

NVIDIA Releases New Physical AI Models as Global Partner LEM Surgical Unveils Next-Generation Robot

An Important Update Regarding Our CAP-002 Program: A Letter to the STXBP1 Community

Transforming Cancer Treatment with the Power of the Immune System

Researchers have created the first map of lipid transport in cells

Warning: Selenium and zinc picolinate-containing products for children

PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight® Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows

Whooping cough vaccination during pregnancy strengthens the immune system in newborns

BTIG Announces Strategic Hire for TMT Investment Banking

Lydia’s story

The long game of American reindustrialization

D-Wave Quantum acquires ARCH-backed Quantum Circuits to accelerate the development of quantum computers

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards

Arkadiankadun siltaremontti aiheuttaa muutoksia liikennejärjestelyihin Luonnontieteellisen museon lähistöllä

Precision testing options for pathologists

Partners in cancer care

Bambusa Therapeutics Announces First Patient Dosed in Phase Ib Proof-of-Concept COPD Study of BBT002, Reinforcing Bispecific Pipeline Momentum

LEM Surgical Showcased in NVIDIA CES 2026 Keynote

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment

Pierre Fabre, un modèle d'excellence en actionnariat salarié

AbelZeta to Attend 44th Annual J.P. Morgan Healthcare Conference and Join Panel Discussion

Números de Contacto de Consejo Superior de Salud Pública

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

Updating of summaries of product characteristics due to changed ATC codes for 2026

Working with Halozyme ENHANZE® Technology for Higher Dosing

Using Arecor’s Arestat Technology to Increase Drug Dosing

Unlocking Solutions to Deliver Higher Doses

Prof. Akiyuki Taruno has taken up his post in the Cellular and Molecular Physiology

Olympus to Present at J.P. Morgan Healthcare Conference

GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

The Evolution of Health Literacy: Challenges, Opportunities for Trial Recruitment in the Digital Age

Sysmex Selected for CDP 2025 âClimate Changeâ A List